Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Cynthiana › NPI 1497247894
Lab

My Turning Point, LLC

My Turning Point, LLC was paid $6.91M by Medicaid between Dec 2018 and Sep 2022, across 27 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 26% of everything it billed.

33Billing provider infoMY TURNING POINT, LLC
CYNTHIANA, KY 41031
33aNPI1497247894assigned 05/31/2018
28Total paid$6.91M
24GClaims139,216
24DCodes billed27
24AFirst – last monthDec 2018 – Sep 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in Kentucky

Rank by total paid#14 of 73
Median peer was paid$95K
This provider vs. median73×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018166$6K
201925,133$1.04M
202035,603$1.75M
202146,760$2.53M
202231,554$1.58M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 26% 12,447 10,023 $1.80M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 24% 40,131 18,065 $1.65M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 20% 36,060 16,848 $1.40M
T2023 Targeted case management; per month 12% 2,989 2,305 $795K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 4.9% 5,084 3,245 $338K
H2027 Psychoeducational service, per 15 minutes 2.6% 5,128 3,836 $178K
90832 Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient 2.1% 4,308 3,293 $148K
90853 Group psychotherapy (other than of a multiple-family group) 1.6% 9,098 6,291 $110K
H0038 Self-help/peer services, per 15 minutes 1.6% 9,295 4,119 $108K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1.4% 2,050 1,385 $99K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 1,041 675 $66K
90791 Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation <1% 811 730 $62K
15 more codes
T1007 Alcohol and/or substance abuse services, treatment plan development and/or modification <1% 1,025 $49K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,703 $32K
81025 <1% 3,187 $18K
99406 <1% 2,377 $12K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 411 $12K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 105 $9K
90792 Psychiatric diagnostic evaluation with medical services <1% 62 $6K
99441 <1% 221 $5K
G0659 Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes <1% 148 $3K
99442 <1% 75 $3K
80305 <1% 120 $945.43
90834 Psychotherapy session, about 45 minutes <1% 24 $575.69
97154 <1% 147 $417.24
36415 Collection of venous blood by venipuncture <1% 92 $172.78
90863 0% 77 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHAY, DWAYNE (MEMBER/MANAGER)